Lifetime Risk of Hepatorenal Events Assessed in Longitudinal Cohort of Renal Transplant Recipients with HBV Infection
Transplantation Proceedings · 2023-09 · 55 (7) · 1581-1587
DOI: 10.1016/j.transproceed.2023.05.017 ↗Kurz gefasst
Fachartikel in der Zeitschrift Transplantation Proceedings, 2023-09. Verfasst von Kevin Lu und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Taichung Veterans General Hospital, Taichung, Taiwan; School of Medicine, National Yang-Ming Chiao Tung University, Taipei, Ta…. Hauptthemen laut MEDLINE: Kidney Transplantation, Hepatitis B, Kidney Failure, Chronic. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 27 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Kidney transplantation is a treatment option for patients with end-stage renal disease (ESRD) who are infected with hepatitis B virus (HBV). However, the impact of nucleos(t)ide analogues usage on the clinical outcomes in HBV-infected ESRD patients undergoing kidney transplantation is not well understood. This study aimed to assess the outcomes of kidney transplant recipients with HBV infection using real-world data to provide insight into the disease course over time. METHODS: A nationwide retrospective longitudinal population-level cohort study was conducted using the National Health Insurance Research Database. The study evaluated patient and allograft survival and kidney-related and liver-related events and identified factors contributing to these events. RESULTS: Of the 4838 renal transplant recipients in the study, there were no significant differences in graft survival between the HBV-infected and non-infected groups (P = .244). However, the HBV-infected group had suboptimal patient survival compared to the non-infected group (hazard ratio [HR] for overall survival, 1.80; 95% CI 1.40-2.30; P 60 years (HR, 6.90; 95% CI, 3.14-15.19; P < .001) were associated with increased incidence of liver cancer. CONCLUSIONS: Hepatitis B-infected renal transplant recipients have comparable graft survival but inferior patient survival outcomes due to pre-existing diseases and increasing liver-related complications. The findings of this study can help optimize treatment strategies and improve long-term outcomes for this patient population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Urology, Taichung Veterans General Hospital, Taichung, Taiwan; School of Medicine, National Yang-Ming Chiao Tung University, Taipei, Taiwan. Electronic address: kevinlu0620@mail2000.com.tw.
- Department of Urology, Taichung Veterans General Hospital, Taichung, Taiwan; School of Medicine, National Yang-Ming Chiao Tung University, Taipei, Taiwan; Department of Applied Chemistry, National Chi Nan University, Na…
Zitieren
APA
Lu, K., & Chiu, K. Y. (2023). Lifetime Risk of Hepatorenal Events Assessed in Longitudinal Cohort of Renal Transplant Recipients with HBV Infection. Transplantation Proceedings, 55(7), 1581-1587. https://doi.org/10.1016/j.transproceed.2023.05.017
Vancouver
Lu K, Chiu KY. Lifetime Risk of Hepatorenal Events Assessed in Longitudinal Cohort of Renal Transplant Recipients with HBV Infection. Transplantation Proceedings. 2023;55(7):1581-1587. doi:10.1016/j.transproceed.2023.05.017
BibTeX
@article{Lu2023,
author = {Lu, Kevin and Chiu, Kun-Yuan},
title = {Lifetime Risk of Hepatorenal Events Assessed in Longitudinal Cohort of Renal Transplant Recipients with HBV Infection},
journal = {Transplantation Proceedings},
year = {2023},
volume = {55},
number = {7},
pages = {1581--1587},
doi = {10.1016/j.transproceed.2023.05.017}
}
EUVIMED